Farmak’s specialists have confirmed the falsification of two “Amizon” batches

Farmak’s management officially informs that since March 01, 2013 there takes effect the ba...

Mar 05, 2013

Farmak JSC opens the representative office in Kyrgyzstan

A leader of the pharmaceutical market, Farmak JSC opens the representative office in Kyrgy...

Feb 28, 2013

Farmak JSC sums up the year 2012

Domestic pharmaceutical manufacturer, Farmak JSC sums up the results gained in the year 20...

Feb 18, 2013

Farmak JSC has introduced Corvalol in tablets to the market

At the beginning of 2013 Farmak JSC started manufacturing Corvalol in a new pharmaceutical...

Feb 11, 2013

Farmak JSC participated in the “Back to Work” project presentation

The project “Back to Work”: mothers’ and fathers’ reintegration after the child-care leave...

Feb 01, 2013

Farmak JSC has introduced L’esfal hepatoprotector to the market

Farmak’s specialists have developed L’esfal hepatoprotective drug of broad use spectrum an...

Jan 25, 2013

Farmak JSC has improved the formula of Injesta ampoule progesterone

Farmak’s specialists have improved the formula of Injesta ampoule progesterone. The improv...

Jan 17, 2013

Farmak JSC has developed the drug to treat arterial hypertension called Ramizes ...

Farmak JSC has developed and launched into the market the arterial hypertension drug for t...

Jan 11, 2013

Farmak’s Employees Help the Orphaned Children

In December, 2012 Farmak’s employees participated in the charity campaign. They gathered t...

Dec 21, 2012
Show more